Augmedix, Inc.

AUGX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$19,171-$24,449-$17,851-$15,604
Dep. & Amort.$1,098$856$691$867
Deferred Tax-$1,322$0-$2,057$744
Stock-Based Comp.$2,471$2,112$1,387$668
Change in WC-$1,823$874-$1,998-$1,020
Other Non-Cash$3,306$3,834$1,236-$54
Operating Cash Flow-$15,441-$16,773-$18,592-$14,399
Investing Activities
PP&E Inv.-$3,105-$1,408-$611-$647
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$3,105-$1,408-$611-$647
Financing Activities
Debt Repay.$5,000-$1,125$2,034$2,680
Stock Issued$38,735$30$40,000$27,417
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$365-$112-$4,207-$3,680
Financing Cash Flow$43,370-$1,237$37,827$26,417
Forex Effect-$470-$181-$10-$1
Net Chg. in Cash$24,966-$19,599$18,614$11,370
Supplemental Information
Beg. Cash$21,376$41,587$22,973$11,603
End Cash$46,342$21,988$41,587$22,973
Free Cash Flow-$18,546-$18,181-$19,203-$15,046
Augmedix, Inc. (AUGX) Financial Statements & Key Stats | AlphaPilot